Serge Belanger
Stock Analyst at Needham
(4.68)
# 167
Out of 5,131 analysts
384
Total ratings
58.54%
Success rate
26.59%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KALV KalVista Pharmaceuticals | Maintains: Buy | $32 → $35 | $16.80 | +108.33% | 24 | Jan 9, 2026 | |
| PCRX Pacira BioSciences | Maintains: Buy | $30 | $23.53 | +27.50% | 29 | Jan 9, 2026 | |
| CRMD CorMedix | Maintains: Buy | $16 → $15 | $7.63 | +96.59% | 20 | Jan 8, 2026 | |
| COLL Collegium Pharmaceutical | Maintains: Buy | $48 → $56 | $45.54 | +22.97% | 27 | Jan 8, 2026 | |
| EOLS Evolus | Reiterates: Hold | n/a | $5.65 | - | 17 | Dec 24, 2025 | |
| VRDN Viridian Therapeutics | Maintains: Buy | $34 → $42 | $31.73 | +32.37% | 19 | Dec 23, 2025 | |
| CYTK Cytokinetics | Maintains: Buy | $72 → $84 | $62.51 | +34.38% | 26 | Dec 22, 2025 | |
| OCUL Ocular Therapeutix | Reiterates: Buy | $20 | $11.26 | +77.62% | 6 | Dec 8, 2025 | |
| OCS Oculis Holding AG | Reiterates: Buy | $36 | $23.07 | +56.05% | 2 | Nov 11, 2025 | |
| AMPH Amphastar Pharmaceuticals | Maintains: Buy | $36 → $34 | $27.74 | +22.57% | 8 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $46 | $34.37 | +33.84% | 10 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $7.40 | +143.24% | 18 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $52 | $35.86 | +45.01% | 34 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $42.15 | +30.49% | 13 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $30 | $28.22 | +6.31% | 23 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $12.49 | - | 9 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $66 → $20 | $18.49 | +8.17% | 14 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.39 | +115.83% | 23 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $22 | $11.18 | +96.78% | 22 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $7.95 | - | 19 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $3.88 | +3.09% | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.52 | - | 1 | Mar 31, 2022 |
KalVista Pharmaceuticals
Jan 9, 2026
Maintains: Buy
Price Target: $32 → $35
Current: $16.80
Upside: +108.33%
Pacira BioSciences
Jan 9, 2026
Maintains: Buy
Price Target: $30
Current: $23.53
Upside: +27.50%
CorMedix
Jan 8, 2026
Maintains: Buy
Price Target: $16 → $15
Current: $7.63
Upside: +96.59%
Collegium Pharmaceutical
Jan 8, 2026
Maintains: Buy
Price Target: $48 → $56
Current: $45.54
Upside: +22.97%
Evolus
Dec 24, 2025
Reiterates: Hold
Price Target: n/a
Current: $5.65
Upside: -
Viridian Therapeutics
Dec 23, 2025
Maintains: Buy
Price Target: $34 → $42
Current: $31.73
Upside: +32.37%
Cytokinetics
Dec 22, 2025
Maintains: Buy
Price Target: $72 → $84
Current: $62.51
Upside: +34.38%
Ocular Therapeutix
Dec 8, 2025
Reiterates: Buy
Price Target: $20
Current: $11.26
Upside: +77.62%
Oculis Holding AG
Nov 11, 2025
Reiterates: Buy
Price Target: $36
Current: $23.07
Upside: +56.05%
Amphastar Pharmaceuticals
Nov 7, 2025
Maintains: Buy
Price Target: $36 → $34
Current: $27.74
Upside: +22.57%
Nov 5, 2025
Maintains: Buy
Price Target: $40 → $46
Current: $34.37
Upside: +33.84%
Nov 4, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $7.40
Upside: +143.24%
Nov 4, 2025
Maintains: Buy
Price Target: $36 → $52
Current: $35.86
Upside: +45.01%
Nov 4, 2025
Reiterates: Buy
Price Target: $55
Current: $42.15
Upside: +30.49%
Oct 28, 2025
Maintains: Buy
Price Target: $22 → $30
Current: $28.22
Upside: +6.31%
Oct 15, 2025
Reiterates: Hold
Price Target: n/a
Current: $12.49
Upside: -
Sep 30, 2025
Maintains: Buy
Price Target: $66 → $20
Current: $18.49
Upside: +8.17%
Aug 8, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.39
Upside: +115.83%
Aug 8, 2025
Maintains: Buy
Price Target: $24 → $22
Current: $11.18
Upside: +96.78%
May 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $7.95
Upside: -
May 7, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $3.88
Upside: +3.09%
Mar 31, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.52
Upside: -